NEW DELHI, Jan 14: Amid a rise in Covid cases in some countries, Serum Institute of India has started supply of Covishield to the Centre free of cost with the first lot of 80 lakh doses set to be dispatched from Saturday, official sources said. Since the launch of the anti-Covid vaccination drive, SII has so far provided 170 crore doses of Covishield to the Government. According to an official source, Prakash Kumar Singh, Director – Government and Regulatory Affairs […]
CEO of Serum Institute of India, Adar Poonawalla stated that their Covovax vaccine will be approved as a COVID-19 Booster dose in the next 10 to 15 days. He further said that the vaccine is highly effective against the Omicron variants of coronavirus. Covovax is the indigenous version of a Covid vaccine developed by Novovax
CEO of Serum Institute of India, Adar Poonawalla stated that their Covovax vaccine will be approved as a COVID-19 Booster dose in the next 10 to 15 days. He further said that the vaccine is highly effective against the Omicron variants of coronavirus. Covovax is the indigenous version of a Covid vaccine developed by Novovax